Updated Jul 16, 2026
Van Tuyl Christopher has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.02M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-10 | IMVT | Immunovant, Inc. | S — Open-market sale | 63 | $39.99 | $3K |
| 2026-07-10 | IMVT | Immunovant, Inc. | S — Open-market sale | 1.1K | $39.53 | $45K |
| 2026-06-26 | IMVT | Immunovant, Inc. | S — Open-market sale | 2.8K | $38.96 | $111K |
| 2026-06-26 | IMVT | Immunovant, Inc. | S — Open-market sale | 15.0K | $38.19 | $572K |
| 2026-06-26 | IMVT | Immunovant, Inc. | M — Option exercise | 17.8K | $15.20 | $271K |
| 2026-06-22 | IMVT | Immunovant, Inc. | S — Open-market sale | 2.6K | $35.39 | $93K |
| 2026-04-10 | IMVT | Immunovant, Inc. | S — Open-market sale | 5.2K | $24.83 | $128K |
| 2026-04-09 | IMVT | Immunovant, Inc. | A — Grant or award | 41.3K | $0.00 | |
| 2026-03-20 | IMVT | Immunovant, Inc. | S — Open-market sale | 2.9K | $24.97 | $72K |
| 2024-12-18 | IMVT | Immunovant, Inc. | A — Grant or award | 110.0K | $0.00 |
Van Tuyl Christopher is a corporate insider — currently tracked as Chief Legal Officer of Immunovant, Inc. (IMVT). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 7 open-market sales ($1.02M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Van Tuyl Christopher profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.